ClinicalTrials.Veeva

Menu

Xpert® Hemorrhagic Fever on the GeneXpert® Edge X System

C

Cepheid

Status

Completed

Conditions

Hemorrhagic Fever

Treatments

Diagnostic Test: Xpert Hemorrhagic Fever test

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

A multi-site observation study that was conducted a geographically diverse sites across the United States

Full description

Capillary and venous whole blood specimens were prospectively collected from consented individuals symptomatic or asymptomatic of fever

Enrollment

408 patients

Sex

All

Ages

14+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Capillary and venous whole blood specimens from blood donors who symptomatic for fever lasting ≤ 10 days OR asymptomatic for fever
  • Whole blood specimens collected in EDTA specimens collection devices only

Exclusion criteria

  • Any whole blood specimens from blood donors vaccinated with a Hemorrhagic Fever live virus vaccine within the past 28 days
  • Any whole blood specimen that were previously enrolled
  • Any whole blood specimens not collected according to the manufacturer's instructions

Trial design

408 participants in 1 patient group

Capillary and venous whole blood specimens
Description:
whole blood specimens from individuals asymptomatic or symptomatic of fever
Treatment:
Diagnostic Test: Xpert Hemorrhagic Fever test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems